Recent articles

Drugs for COVID-19: tocilizumab

Published studies into the effects of tocilizumab in the treatment of patients with COVID-19 differ greatly in the way they have been designed and conducted. Comparisons are hampered by difference ...

In short Read article


Erlotinib (Tarceva®) was the first EGFR tyrokinase inhibitor to be authorized for the treatment of non-small-cell lung carcinoma (NSCLC). It enabled outpatient treatment, and has a more favourable ...

In short Read article

An app as a medical device?

The use of apps as medical devices can be advantageous for both patients and care providers, on condition that these products are thoroughly investigated and conform to the requirements for medica ...

In short Read article